Dare Bioscience (DARE) EBIT (QoQ) (2016 - 2025)
Dare Bioscience (DARE) EBIT (QoQ) (2016 - 2025) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.04 Bn | 130.18 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.98 Bn | 77.98 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.37 Bn | 59.19 Bn | 1.37 Bn |
| 4 | Moderna | 57.67 Bn | 52.53 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.94 Bn | 36.84 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 30.58 Bn | 27.27 Bn | 992.69 Mn |
| 7 | BioNTech SE | 27.75 Bn | 9.35 Bn | 668.28 Mn |
| 8 | Insmed | 27.24 Bn | 26.08 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.03 Bn | 26.20 Bn | - |
| 10 | Dare Bioscience | 12.21 Mn | -406,442.64 | -132,343.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 59.93% |
| Sep 30, 2025 | 4.07% |
| Jun 30, 2025 | 16.44% |
| Mar 31, 2025 | 14.98% |
| Dec 31, 2024 | -15.10% |
| Sep 30, 2024 | 36.39% |
| Jun 30, 2024 | -22.20% |
| Mar 31, 2024 | -16.46% |
| Dec 31, 2023 | 38.41% |
| Sep 30, 2023 | 6.60% |
| Jun 30, 2023 | -7.24% |
| Mar 31, 2023 | 48.35% |
| Dec 31, 2022 | -127.36% |
| Sep 30, 2022 | -1,957.50% |
| Jun 30, 2022 | 104.58% |
| Mar 31, 2022 | 11.97% |
| Dec 31, 2021 | 24.67% |
| Sep 30, 2021 | -38.26% |
| Jun 30, 2021 | -19.10% |
| Mar 31, 2021 | 8.85% |